register

News & Trends - Pharmaceuticals

Medicines Australia, MTAA and AusBiotech support enhanced mental health services

Health Industry Hub | May 11, 2020 |

Australia’s suicide rate may increase by 25 per cent, and it is likely that about 30 per cent of those will be among young people, as the longer-term impact of the COVID-19 pandemic is experienced across the community.

Modelling from the University of Sydney’s Brain and Mind Centre predicts an additional 750 to 1,500 suicides in addition to the 3,000 lives that are lost to suicide already every year in Australia.

In response to this mental health need, the Federal Government made an initial commitment of $74 million to boost mental health services. In collaboration with the National Mental Health Commission, leading mental health organisations, experts and influencers worked together to develop the national campaign #InThisTogether.

Register FREE & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

Medicines Australia CEO Elizabeth de Somer said “Medicines Australia welcomes the Federal Government’s $74M boost to mental health services. This, and the launch of the #InThisTogether national online campaign will provide all Australians with connections to essential mental health services and wellbeing information. The COVID-19 pandemic has forced us all to radically change our lives, and compounded with heightened levels of anxiety and uncertainty, it is more important than ever that we support each other emotionally and with sensitivity and to stay connected to our communities, families and workplaces.”

Medical Technology Association of Australia (MTAA) CEO Ian Burgess said “We congratulate the Morrison Government for their efforts in helping to flatten the curve so far, but also recognise that the mental health impacts of this crisis will extend out far beyond the physical ones, and it is incumbent on industry to continue to show leadership in our advocacy and our workplaces.”

Lorraine Chiroiu CEO of AusBiotech said “COVID-19 has disrupted all of our assumptions, norms and expectations. It’s tough, and so AusBiotech welcomes the Government’s broad support for Australia’s health – mental and physical. While we are natural collaborators in our work, ensuring the deeper connections to support each other is key, and I encourage the life sciences community to reach out and seek support as we move through this together.”

You may also like PRIME Awards 2020 call for entries – The only awards program dedicated to recognising excellence within Australian healthcare communications, is now open for entries.


News & Trends - Biotechnology

AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm

AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm

Health Industry Hub | April 23, 2024 |

Biotech News: AusBiotech, the nation’s leading industry body for the biotech sector, has named former leader at Sanofi, Rebekah Cassidy, […]

More


News & Trends - MedTech & Diagnostics

Federal government invests in Siemens Healthineers scanner to 'reduce wait times' for cancer diagnosis

Federal government invests in Siemens Healthineers scanner to ‘reduce wait times’ for cancer diagnosis

Health Industry Hub | April 23, 2024 |

MedTech & Diagnostics News: The Albanese Government is investing $12 million through the 2024–25 Budget, to purchase and install a […]

More


News & Trends - MedTech & Diagnostics

Cardiac device benefits face more cuts, while technical services remain secure in the short term

Cardiac device benefits face more cuts, while technical services remain secure in the short term

Health Industry Hub | April 23, 2024 |

MedTech & Diagnostics News: Starting from July 2024, Cardiac Implantable Electronic Devices (CIED) listed on the Prescribed List (PL) will […]

More


News & Trends - Biotechnology

CSL's world-first gene therapy heads for MSAC assessment

CSL’s world-first gene therapy heads for MSAC evaluation

Health Industry Hub | April 23, 2024 |

Biotech News: CSL’s world-first gene therapy for haemophilia B is scheduled for consideration at the upcoming Medical Services Advisory Committee (MSAC) […]

More


This content is copyright protected. Please subscribe to gain access.